The FDA approves Roche’s (OTCQX:RHHBY -0.1%) cobas vivoDx MRSA diagnostic test to detect methicillin-resistant Staphylococcus aureus (MRSA) bacterial colonization in nasal swab samples.
Results from the bioluminescence assay are generated in as little as five hours.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.